C12N 2740/15021
Viruses as such
Official title: Viruses as such, e.g. new isolates, mutants or their genomic sequences
C12N2740/15021 (Viruses as such) appears on 51 US grants and 64 published applications in this corpus.
Search patents in C12N- Granted patents
- 51
- Published applications
- 64
- Assignees
- 50
- Inventors
- 146
- Latest grant
- 17 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1991 | 1 | 0 |
| 1992 | 2 | 0 |
| 1993 | 0 | 0 |
| 1994 | 3 | 0 |
| 1995 | 2 | 0 |
| 1996 | 2 | 0 |
| 1997 | 3 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 1 |
| 2002 | 0 | 0 |
| 2003 | 4 | 6 |
| 2004 | 2 | 4 |
| 2005 | 0 | 0 |
| 2006 | 1 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 1 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 1 |
| 2014 | 0 | 2 |
| 2015 | 0 | 3 |
| 2016 | 4 | 2 |
| 2017 | 0 | 4 |
| 2018 | 3 | 3 |
| 2019 | 3 | 4 |
| 2020 | 3 | 3 |
| 2021 | 2 | 9 |
| 2022 | 0 | 1 |
| 2023 | 5 | 6 |
| 2024 | 4 | 7 |
| 2025 | 3 | 2 |
| 2026 | 1 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Method for large-scale preparation of purified preparation of recombinant lentiviral vector at GMP grade17 Mar 2026US 12,577,541 B2Abelzeta Inc.
- Bispecific chimeric antigen receptors and encoding polynucleotides, vectors and cells thereof11 Nov 2025US 12,466,885 B2Seattle Children's Hospital
- Pre-immunization and immunotherapy29 Jul 2025US 12,370,253 B2American Gene Technologies International Inc.
- GD2-based chimeric antigen receptor and application thereof7 Jan 2025US 12,187,808 B2Beijing Meikang Geno-Immune Biotechnology Co., Ltd.
- Bispecific chimeric antigen receptors, encoding polynucleotides and use of receptors thereof to treat cancer17 Sep 2024US 12,091,459 B2Seattle Children's Hospital
- Recombinant retrovirus, compositions, and methods of use30 Jul 2026US 2026/0218136 A1Kelonia Therapeutics, Inc.
- Bispecific chimeric antigen receptors and encoding polynucleotides, vectors and cells thereof25 Jun 2026US 2026/0176356 A1Seattle Children's Hospital d/b/a Seattle Children's Research Institute
- Bispecific chimeric antigen receptors and encoding polynucleotides, vectors and cells thereof25 Jun 2026US 2026/0176357 A1Seattle Children's Hospital d/b/a Seattle Children's Research Institute
- Method for large-scale preparation of purified preparation of recombinant lentiviral vector at gmp grade25 Jun 2026US 2026/0176595 A1Abelzeta Inc.
- Hiv pre-immunization and immunotherapy17 Apr 2025US 2025/0121051 A1American Gene Technologies International Inc.
Most cited
By later US patents
- Bispecific chimeric antigen receptors and encoding polynucleotides thereof92US 9,447,194 B2Seattle Children's Hospital · 2016
- Feline t-lymphotropic lentivirus38US 5,037,753 AThe Regents of the University of California · 1991
- Feline T-lymphotropic lentivirus assay35US 5,118,602 AThe Regents of the University of California · 1992
- Bispecific chimeric antigen receptors and methods of use thereof to treat cancer26US 10,189,903 B2Seattle Children's Hospital · 2019
- HIV pre-immunization and immunotherapy25US 10,036,038 B2American Gene Technologies International Inc. · 2018